Furthermore, AMPK activation suppresses the TGF-β and NF-κB pathways, reducing the production of pro-fibrotic and inflammatory factors, thereby alleviating renal fibrosis and inflammation (32). The gene discussed is TGFB1; the disease is renal fibrosis.